Live by the EpiPen, die by the EpiPen
Zach Shallbetter

Thank you for your clearly stated article. Because you need the medication yourself, you were able to describe first hand how terrifying it is when you had an attack. Since this topic first emerged, there were people saying that it was possible to get the medication cheaply along with the syringes and I thought, what person going into shock is going to be able to draw a syringe when you are feeling “A tightness that can only be compared to drowning while having a heart attack”? What a lot of people do not seem to realize (as indicated in a comment below) is that time is of the essence. A person going into shock does not have time to draw a syringe. A device that is ready to go is needed to get the medication immediately into you. People who use syringes on a daily basis may have a chance to draw a syringe in a panic, but the average person who only occasionally has a need to draw a syringe would be more likely to fumble in a panic situation.

I do not use the product and have no idea about a generic version mentioned below. But, as to the cost, when a CEO outrageously raises the cost of an absolutely necessary product and then outrageously raises her/his own salary ( in this case from $2+million to $18+ million) it has NOTHING to do with government controls, insurance, markets, demand and supply — it has only to do with greed. It looks to me as though the product line was scoured to find a product that people absolutely needed and would continue to purchase (sustainability), regardless of price, so that the price could be dramatically increased to justify the salary she wanted for herself — bigger profits for the company (stockholders should be happy) and for herself. But the cost of living for the consumer goes up, again, outrageously, and wages do not. Wouldn’t it be just great if we all could just say, hey, I’m worth $18M and raise our own salaries?

Show your support

Clapping shows how much you appreciated stephanie sewell’s story.